Guidelines

• NCCN Guidelines Version 1.2022

Evidence Blocks

• NCCN Guidelines with Evidence Blocks Version 8.2021

Frameworks

• Basic Resources (English) Version 3.2020 (Preliminary)

• Core Resources (English) Version 3.2020 (Preliminary)

• Enhanced Resources (English) Version 3.2020 (Preliminary)

Guidelines for Patients

• Invasive Breast Cancer-English Version 2020

• Metastatic Breast Cancer-English Version 2020

• DCIS Breast Cancer-English Version 2020

• Invasive Breast Cancer-Russian Version 2018

• Metastatic Breast Cancer-Russian Version 2018

• DCIS Breast Cancer-Russian Version 2018

• Metastatic Breast Cancer-French Canadian Version 2018

• Invasive Breast Cancer-French Canadian Version 2018

• DCIS Breast Cancer-French Canadian Version 2018

Educational Events and Programs

Calendar of Events

Continuing Education

• HER2-Positive Breast Cancer: A Guide Through An Evolving Treatment Landscape

• Understanding/Addressing Health Disparities to Improve Breast Cancer Care

• Genetic Testing in Patients with Breast Cancer: Who Should Get Tested?

• Surgical and Radiation Treatment Updates to Management of Breast Cancer, Including SABCS Updates

• Adjuvant and Neoadjuvant Therapies for Breast Cancer, Including SABCS Updates

• Breast Cancer in Young Adults: Treatment Considerations and Supportive Care Options

• Updates to the Systemic Treatment of Metastatic Breast Cancer, Including SABCS Updates

• Management of Breast Cancer Brain Metastases

• Breast Cancer Survivors: Issues and Recommendations

• NCCN Guidelines® Insights - Breast Cancer, Version 4.2021

• Challenging Case Review: Breast Cancer

• NCCN Guidelines® Update: HER2-Positive Breast Cancer

• NCCN Guidelines® Update: Triple Negative Breast Cancer

• Monthly Oncology Tumor Boards: Brain Metastases in Breast Cancer

International

Disclosures

• Disclosure Policy

• Panel Member Disclosures

• Panel Member Disclosures by Meeting Date

• End User License Agreement